Stockscreener 앱 받기
4.965
3.12%
-0.16
전일 마감가:
$5.125
열려 있는:
$5.15
하루 거래량:
186.20K
Relative Volume:
0.95
시가총액:
$140.13M
수익:
$61.86M
순이익/손실:
$-11.43M
주가수익비율:
-10.31
EPS:
-0.4818
순현금흐름:
$-12.52M
1주 성능:
-21.32%
1개월 성능:
-31.89%
6개월 성능:
-3.97%
1년 성능:
-32.91%
1일 변동 폭
$4.78
$5.18
1주일 범위
$4.78
$6.435
52주 변동 폭
$4.31
$9.555
Journey Medical Corp Stock (DERM) Company Profile
명칭
Journey Medical Corp
전화
480-434-6670
주소
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
Compare DERM vs TAK, TEVA, HLN, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DERM
Journey Medical Corp
|
4.965 | 140.13M | 61.86M | -11.43M | -12.52M | -0.4818 |
TAK
Takeda Pharmaceutical Co Adr
|
19.67 | 62.84B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
41.50 | 48.40B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
10.13 | 44.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
79.38 | 32.80B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
533.12 | 22.87B | 3.17B | 1.29B | 1.01B | 27.09 |
Journey Medical Corp Stock (DERM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-25 | 개시 | H.C. Wainwright | Buy |
| 2025-07-30 | 재개 | B. Riley Securities | Buy |
| 2024-08-22 | 개시 | Rodman & Renshaw | Buy |
| 2024-06-28 | 재개 | ROTH MKM | Buy |
| 2021-12-07 | 개시 | B. Riley Securities | Buy |
Journey Medical Corp 주식(DERM)의 최신 뉴스
An investment adviser reports passive ownership of 2.45M shares in Journey Medical (DERM). - Stock Titan
Fortress Biotech repays $15 million Oaktree credit facility in full By Investing.com - Investing.com India
Fortress Biotech repays $15 million Oaktree credit facility in full By Investing.com - Investing.com UK
7 Best Travel & Tourism Stocks for 2026 and How to Invest - The Motley Fool
Are Options Traders Betting on a Big Move in Journey Medical Stock? - Zacks Investment Research
Journey Medical Corporation $DERM Shares Sold by Opaleye Management Inc. - marketbeat.com
Journey Medical Corporation to Participate in September 2026 Investor Conferences - Yahoo Finance
Shinon Healthcare Receives Honors at Sanjeevani 2026 for Medical Value Travel Leadership, Advancing the 'Heal in India' Vision - indiagazette.com
Fortress Biotech's business presentation goes online Sept. 11 - Stock Titan
Nine FDA-approved skin drugs are marketed by Journey Medical. Its CEO will join two investor events. - Stock Titan
DERM 8-K FilingsJourney Medical Corporation SEC 8-K - Stock Titan
Journey Medical Corp (DERM) Key Financial Ratios – Valuation, Profitability & More - Value Research
Audubon’s Globus Medical Acquires Duke Spinout Higgs Boson Health - BioBuzz
7 Best Travel Insurance Companies of May 2026 - money.com
Journey Medical Corp (DERM) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
536,000 Shares in Journey Medical Corporation $DERM Acquired by Punch & Associates Investment Management Inc. - MarketBeat
J. Goldman & Co LP Takes Position in Journey Medical Corporation $DERM - MarketBeat
DERM | Journey Medical Corporation Common FinancialsRevenue Breakdown - Quiver Quantitative
Journey Medical: Q2 Report Confirms Thesis On Track As Emrosi Launch Gains Traction - Seeking Alpha
FY2026 EPS Estimates for Journey Medical Lowered by Analyst - MarketBeat
Teleconferência de Resultados do 2T26 da Journey Medical (FBIO): Receita cresce 23% com aceleração do Emrosi - TradingKey
Q3 EPS Estimates for Journey Medical Cut by HC Wainwright - MarketBeat
Conferencia de resultados del T2 de 2026 de Journey Medical (FBIO): los ingresos aumentan un 23% a medida que Emrosi se acelera - TradingKey
Journey Medical (FBIO) Q2 2026 Earnings Call: Revenue Rises 23% as Emrosi Accelerates - tradingkey.com
Analyst Reiterates Buy on Journey Medical as Emrosi Outperformance Supports Unchanged $13 Price Target - TipRanks
Profound Medical Launches ‘Let's Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey - The Manila Times
Journey Medical's (DERM) Buy Rating Reaffirmed at B. Riley Financial - MarketBeat
Why is Journey Medical stock rallying today? - Investing.com
Why is Journey Medical stock rallying today? By Investing.com - Investing.com Canada
Why is Journey Medical stock rallying today? By Investing.com - Investing.com UK
Why is Journey Medical stock rallying today? - Investing.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
A. G. P. Maintains Journey Medical(DERM.US) With Buy Rating, Cuts Target Price to $14 - Moomoo
Wasatch Advisors LP Buys 725,560 Shares of Journey Medical Corporation $DERM - MarketBeat
Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - manilatimes.net
Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - GlobeNewswire
Journey Medical earnings beat by $0.12, revenue topped estimates - Investing.com Canada
Journey Medical Corp (DERM) (Q2 2026) Earnings Call Highlights: Emrosi Surges 20% Sequentially, ... - Yahoo Finance
Journey Medical earnings beat by $0.12, revenue topped estimates - Investing.com Australia
DERM Looks 49.2% Overvalued on GF Value™ - GuruFocus
Journey Medical Releases Q2 2026 Financial Results - AlphaStreet
Journey Medical Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
Journey Medical Q2 Earnings Call Highlights - MarketBeat
Journey Medical Q2 Earnings Call Highlights - MarketBeat
Here's What Key Metrics Tell Us About Journey Medical (DERM) Q2 Earnings - Yahoo Finance
Journey Medical Corporation (DERM) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Earnings call transcript: Journey Medical tops Q2 2026 forecasts as stock rises - Investing.com
Earnings call transcript: Journey Medical posts Q2 2026 revenue gain, turns EBITDA positive - Investing.com
Earnings call transcript: Journey Medical posts Q2 2026 revenue gain, turns EBITDA positive - Investing.com
Journey Medical earnings beat by $0.12, revenue topped estimates - Investing.com
Journey Medical Corp (DERM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.35%
0.70%
자본화:
|
볼륨(24시간):